Proteomics for cancer biomarker discovery

Clinical Chemistry

Volumn 48, Issue 8, 2002, Pages 1160-1169

  Srinivas, Pothur R ^a   Verma, Mukesh ^a   Zhao, Yinming ^a   Srivastava, Sudhir ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; TUMOR MARKER;

BIOINFORMATICS; DNA MICROARRAY; ELECTROPHORESIS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY;

AFFINITY LABELS; COMPUTATIONAL BIOLOGY; ELECTROPHORESIS; FORECASTING; HUMANS; MASS SPECTROMETRY; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; RESEARCH; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036320438     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry
2. Trends in biomarker research for cancer detection
3. Initial sequencing and analysis of the human genome
4. The sequence of the human genome
5. Proteomics: Unraveling the complexity of heart disease and striving to change cardiology
6. Recent advances in differential display
7. Differential screening of differential display cDNA products by reverse Northern
8. MicroSAGE: A modified procedure for serial analysis of gene expression in limited amounts of tissue
9. Serial analysis of gene expression
10. Correlation between protein and mRNA abundance in yeast
11. A comparison of selected mRNA and protein abundances in human liver
12. High resolution two-dimensional electrophoresis of proteins
13. Weighing naked proteins: Practical, high-accuracy mass measurement of peptides and proteins
14. Emerging tandem-mass-spectrometry techniques for the rapid identification of proteins
15. Protein analysis by mass spectrometry and sequence database searching: Tools for cancer research in the post-genomic era
16. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex
17. Mass spectrometry and the age of the proteome
18. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
19. A protein sequenator
20. Accelerated high-sensitivity microsequencing of proteins and peptides using a miniature reaction cartridge
21. Laser desorption ionization of proteins with molecular masses exceeding 10 000 daltons
22. Analysis of proteins and proteomes by mass spectrometry
23. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases
24. Error-tolerant identification of peptides in sequence databases by peptide sequence tags
25. Mining genomes: Correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases
26. The challenge of developing a sound proteomics strategy
27. Proteomics: The move to mixtures
28. Proteomic approaches to characterize protein modifications: New tools to study the effects of environmental exposures
29. Rapid monitoring of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots
30. Molecular imaging of biochemical samples: Localization of peptides and proteins using MALDI-TOF MS
31. Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues
32. Automated mass spectrometry imaging with a matrix-assisted laser desorption ionization time-of-flight instrument
33. Continuous free-flow electrophoresis separation of cytosolic proteins from the human colon carcinoma cell line LIM 1215: A non two-dimensional gel electrophoresis-based proteome analysis strategy
34. 2D or not 2D
35. Peptide chips for the quantitative evaluation of protein kinase activity
36. New desorption strategies for the mass analysis of macromolecules
37. Recent advancements in surface-enhahced laser desorption/ionization-time of flight mass spectrometry
38. Proteomic strategies for biomarker identification: Progress and challenges
39. The role of cholesterol in the biosynthesis of β-amyloid
40. Cryptic antigenic determinants on the extracellular pyruvate dehydrogenase complex/mimeotope found in primary biliary cirrhosis
41. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease
42. 111Indium-labeled CYT-356 for the detection of occult prostate cancer recurrence
43. Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen
44. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hydridization
45. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy
46. ProteinChip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures
47. Identifying the signature proteins of prostate cancer in seminal plasma by SELDI affinity mass spectrometry
48. Protein profiling of seminal plasma and serum using Ciphergen's SELDI ProteinChip technology for early detection of prostate cancer
49. Tissue array technology for translational research. From gene discovery to application
50. Advances in protein solubilization for two-dimensional electrophoresis
51. Cancer proteomics: From signaling networks to tumor markers
52. Sample preparation of human tumors prior to two-dimensional electrophoresis of proteins
53. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties
54. Specific sample preparation in colorectal cancer
55. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings
56. A distributed system for two-dimensional gel analyses
57. Mining genomes and mapping proteomes: Identification and characterization of protein subunit vaccines
58. RADARS, a bioinformatics solution that automates proteome mass spectral analysis, optimizes protein identification, and archives data in a relational database
59. ProFound: An expert system for protein identification using mass spectrometric peptide mapping information
60. Probability-based protein identification by searching sequence databases using mass spectrometry data
61. Role of accurate mass measurement (± 10 ppm) in protein identification strategies employing MS or MS/MS and database searching
62. Protein identification using mass spectrometric information
63. An approach to correlate tandem mass spectral data of proteins with amino acid sequences in a protein database
64. De novo peptide sequencing via tandem mass spectrometry
65. Cancer proteomics: From identification of novel markers to creation of artificial learning models for tumor classification
66. Use of proteomics patterns in serum to identify ovarian cancer
67. Cancer proteomics: The state of the art
68. Phases of biomarker development for early detection of cancer
69. Laser capture microdissection
70. 2D differential in-gel electrophoresis (DIGE) for the identification of esophageal squamous cell cancer specific protein markers
71. Osteopontin as a potential diagnostic biomarker for ovarian cancer